The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Do Oncologists Believe New Cancer Drugs Offer Good Value?
Open accessAbstract
Learning Objectives: After completing this course, the reader will be able to: Describe how academic oncologists view the costs of new treatments in their treatment recommendations.Discuss academic oncologists’ perceptions of the cost and benefit of one new treatment in light of published results.Describe how academic oncologists view the cost-effectiveness of new treatments relative to previously accepted standards. CME Access and take the CME test online and receive 1 AMA PRA category 1 credit at CME.TheOncologist.com
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
The Role of Cost-effectiveness Analysis in Health and Medicine
Russell, L. B. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540140060028 · Cited by 1,167
Cited by
Cheng, A.-L., Kang, Y.-K., Chen, Z., Tsao, C.-J., Qin, S., Kim, J. S., Luo, R., Feng, J., Ye, S., Yang, T.-S., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70285-7 · Cited by 5,832
Weissleder, R. (2006) · Science · doi:10.1126/science.1125949 · Cited by 1,112
Gupta, K., Miller, J. D., Li, J. Z., Russell, M. W., & Charbonneau, C. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.12.001 · Cited by 974
Targeted Therapies for Hepatocellular Carcinoma
Villanueva, A., & Llovet, J. M. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.03.006 · Cited by 449
Review article: the management of hepatocellular carcinoma
CABRERA, R., & NELSON, D. R. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04200.x · Cited by 222
Metadata
- Authors
- Nadler, E., Eckert, B., & Neumann, P. J.
- Venue
- The Oncologist
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-02-01
- Volume
- 11
- Issue
- 2
- Pages
- 90-95
- ISSN
- 1083-7159 (ISSN-L)
- 1549-490X
- OpenAlex
- W2148199952
- Cited by
- 187
- References
- 2
- FWCI
- 36.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Do Oncologists Believe New Cancer Drugs Offer Good Value? https://app.cochat.ai/papers/10.1634/theoncologist.11-2-90
- The paper
- Nadler, E., Eckert, B., & Neumann, P. J. (2006). Do Oncologists Believe New Cancer Drugs Offer Good Value? The Oncologist. https://doi.org/10.1634/theoncologist.11-2-90
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.